VALUE LINE, INC. ANNOUNCES FIRST QUARTER EARNINGS
Value Line, Inc. 551 Fifth Avenue New York, NY 10176 New York, Sept. 13, 2024 (GLOBE NEWSWIRE) -- Value Line, Inc., (NASDAQ: VALU) reported financial results for the first fiscal…
VERSES AI Inc. Announces 2024 AGSM Results
VANCOUVER, British Columbia, Sept. 13, 2024 (GLOBE NEWSWIRE) -- VERSES AI Inc. (the "Company" or "VERSES") (CBOE Canada: VERS) (OTCQX: VRSSF) is pleased to announce the results of the Annual…
Greystone Logistics Reports Strong Year-End Earnings
TULSA, Okla., Sept. 13, 2024 (GLOBE NEWSWIRE) -- Greystone Logistics, (“Greystone Logistics” or the “Company”) (OTCQB:GLGI) the leading manufacturer of recycled plastic pallets providing sustainable logistics solutions, is pleased to…
Carbeeza Inc. Announces Private Placement Extension
CALGARY, Alberta, Sept. 13, 2024 (GLOBE NEWSWIRE) -- Carbeeza Inc. ("Carbeeza" or the "Company") (TSXV:AUTO) (OTCQB: CRBAF). The TSX Venture Exchange (the "Exchange") has approved an extension until October 11,…
Prairie Provident Announces Loan Amendments and $13.2 Million Equity Rights Offering With $12 Million of Committed Participation
CALGARY, Alberta, Sept. 13, 2024 (GLOBE NEWSWIRE) -- September 13, 2024 – Prairie Provident Resources Inc. ("Prairie Provident" or the "Company") (TSX:PPR) announces an agreement to extend the maturity of…
Gran Tierra Energy Inc. Announces Pricing of an Additional $150 Million Aggregate Principal Amount of its 9.500% Senior Secured Amortizing Notes due 2029
CALGARY, Alberta, Sept. 13, 2024 (GLOBE NEWSWIRE) -- Gran Tierra Energy Inc. (“Gran Tierra” or the “Company”) (NYSE American:GTE)(TSX:GTE)(LSE:GTE) today announced that it has priced its offering of an additional…
Eco Oro Announces Change in Management Team and Board
VANCOUVER, British Columbia, Sept. 13, 2024 (GLOBE NEWSWIRE) -- Eco Oro Minerals Corp. (CSE:EOM) (the “Company”) announced today that Paul Robertson has resigned as Chief Executive Officer of the Company.…
IO Biotech Announces Positive Results from Phase 2 Trial of IO102-IO103 in the First-line Treatment of Advanced Head and Neck Cancer
-- Study Meets Overall Response Rate Primary Endpoint, Encouraging Secondary Endpoint Progression-Free Survival Data in Squamous Cell Carcinoma of the Head and Neck Cohort -- -- No New Safety Signals…
iTeos Announces Clinically Meaningful Objective Response Rate Observed at Every Dose in Follow-up Interim Analysis of GALAXIES Lung-201 Study of Belrestotug + Dostarlimab in First-Line, PD-L1 High Non-Small Cell Lung Cancer Patients
- Clinically meaningful objective response rate (ORR) of 63.3-76.7% observed with belrestotug + dostarlimab combinations, with confirmed ORR (cORR) at ~60% for every dose- >30% cORR difference between belrestotug +…
Avacta Reports Updated Phase 1 Clinical Data of AVA6000 at the European Society for Medical Oncology (ESMO) Congress Demonstrating Multiple Ongoing, Durable Responses in Solid Tumors
This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the…